Charity registration number 1032256
THE ASSOCIATION OF CANCER PHYSICIANS
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021
THE ASSOCIATION OF CANCER PHYSICIANS
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees Dr A Jones Professor R Begent (Appointed 24 February 2021) Secretary Prof. S Ahmed Charity number 1032256 Principal address c/o Mrs A Norton Department of Medicine Royal Marsden Hospital Downs Road, Sutton Surrey SM2 5PT Independent examiner Rouse Partners LLP 55 Station Road Beaconsfield Buckinghamshire HP9 1QL Bankers National Westminster Bank Plc
THE ASSOCIATION OF CANCER PHYSICIANS
CONTENTS
| Page | |
|---|---|
| Trustees report | 1 - 3 |
| Independent examiner's report | 4 |
| Statement of financial activities | 5 |
| Balance sheet | 6 |
| Notes to the accounts | 7 - 12 |
THE ASSOCIATION OF CANCER PHYSICIANS
TRUSTEES REPORT FOR THE YEAR ENDED 31 DECEMBER 2021
The trustees present their annual report and financial statements for the year ended 31 December 2021.
The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the constitution's governing document, the Charities Act 2011 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)”
Objectives and activities
The objectives of the Association of Cancer Physicians (ACP) are to advance the study and practice of cancer medicine (medical oncology), to represent the interests of medical oncologists and to foster the raising of standards in medical care for cancer patients. It is also the aim to facilitate contact between members of the Association and other individuals and organisations concerned with the study and treatment of cancer and with the public at large.
Applications for membership are approved by the Executive Committee and ratified at the AGM. Members and officers of the Executive Committee are nominated by the membership in line with the Constitution and Rules (updated 2013) and a vote of eligible members is organised in the event of a surplus of nominations for the vacant positions. The Chair is appointed for a period of three years that may be extended for a second term of office. The Executive Committee includes Officers in addition to regional representatives and other designated roles. There are up to three representatives of Cancer Physicians in training and one representative of the New Consultants Group on the Executive Committee. Professor David Cunningham took over as Chair of the ACP in November 2017 and Professor Samreen Ahmed is the current Honorary Secretary. Professor Helena Earl is the Honorary President.
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the constitution should undertake.
Achievements and performance
During 2021, the Association of Cancer Physicians continued to support a wide range of activities to advance the study and practice of cancer medicine and to help raise standards of medical care for patients.
The ACP contracts with SAS, an association management company, to provide support for the organisation of the ACP’s programme of educational events, in addition to managing its membership activities and collection of subscriptions. Due to continuing concerns about the COVID-19 pandemic, the AGM was held remotely by Zoom in September 2021, with good attendance. The Executive Committee has found that a virtual AGM helps to facilitate better participation and interaction with the membership from across the UK, in addition to reducing travel for members and reducing costs for all. The meeting is also recorded for members unable to join the live event.
Involvement in cancer physician training, including teaching and education, remains a high priority for the ACP and members were very disappointed that the planned New Consultants Group meeting and the annual study day and trainees’ weekend had to be cancelled in 2020 due to COVID. In 2021 the ACP held a successful meeting for new consultants in Birmingham in September, and a workshop and weekend for trainees in Bristol in October. The workshop was a joint collaboration between the ACP and the BSIR (British Society for Interventional Radiology) and focused on new developments in Interventional Oncology and was well attended both by ACP members and other healthcare professionals. A subsequent book “Problem Solving in Interventional Oncology” is scheduled for publication in late 2022. The trainees’ weekend was very popular and included specific themes of onco-geriatrics and survivorship.
The ACP has been closely involved in the revision of the medical oncology curriculum, overseen by the JRCPTB, as required by the GMC, and the new curriculum was implemented in August 2021. Trainees in medical oncology have to take and pass an exam (Specialist Certificate Exam – SCE), to demonstrate that they have sufficient knowledge to practise safely and competently as consultants.
To provide trainees with additional support with studying for the exam, the ACP is preparing an evidence-based resource to aid revision and support further learning. This new publication is planned for publication in mid 2022.
- 1 -
THE ASSOCIATION OF CANCER PHYSICIANS
TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
The ACP continues to advocate for an expansion in the cancer workforce. Demand for systemic therapy has been increasing year on year, and this growth is expected to continue, due to the pressures of an aging population, an increased incidence of cancer, combined with welcome advances in genomics and therapeutic options. The specialty welcomed the new specialty training numbers in medical oncology allocated in 2021, however feels strongly that this expansion needs to be continued in future years to develop a workforce to deliver world leading cancer services in the future. The ACP is planning a comprehensive workforce census to capture the medical oncology/chemotherapy prescribing workforce, with the granularity that should be very helpful in future workforce planning. The ACP supported a proposed amendment to the Health and Care Bill to strengthen workforce planning.
As in previous years, excellence in research amongst trainees is encouraged by the award of two annual McElwain prizes, one for a clinical project and one for translational research, in addition to a President’s Prize. The three prizewinners presented their work at the National Cancer Research Institute’s annual conference in November 2021 and to their peers at the annual ACP trainees’ weekend in Bristol, in addition to receiving a financial reward.
With the ongoing reduction in many local, regional and national teaching opportunities following the COVID-19 pandemic, the ACP continued their series of monthly teaching webinars. including leading on a joint session with the Royal College of Radiologists looking at acute oncology services. The webinars are supported by pharmaceutical sponsorship and continue to attract sizeable attendances and excellent feedback. The recordings of all the webinars are edited and made available free of charge to all ACP members.
The ACP works closely with EBN Health, an experienced healthcare publishing company, to produce and support its publications. These have been very successful, being awarded the BMA Oncology Prize three years in succession. The most recent book, Problem Solving in Cancer and Fertility, was a joint venture between the ACP and colleagues in obstetrics and gynaecology. The next title in the Problem Solving series will be a book on Interventional Oncology, a collaboration with the British Society of Interventional Radiology, following the successful workshop held in October 2021. The ACP and EBN Health have also established a digital platform as an educational resource to benefit members. This allows access to the full content of the ACP/EBN publications and also includes recordings from the teaching webinars.
The ACP has a reciprocal membership agreement with ESMO (European Society for Medical Oncology), and ESMO representatives sit on the ACP Executive Committee. The ACP collaborates closely with ESMO, and ACP members benefit from a reduced membership subscription to ESMO in addition to access to their extensive programme of activities to support career development. ACP members have contributed to several ESMO surveys looking at the availability of new biotherapies, accessibility to Covid vaccines and the incidence of burnout in oncologists and the ACP is working closely with ESMO to develop resources to support resilience in the oncology workforce.
The ACP continues to be closely involved with and is a parent body of the UK Chemotherapy Board (UKCB), which provides guidance, oversight and support for the continuing development of systemic therapy services across the UK. The UKCB hosts an annual meeting focused on Commissioning Chemotherapy Services, which is well attended,. The UKCB has overseen the development of national regimen specific consent forms for patients undergoing chemotherapy and has established workstreams to undertake audits and produce national guidance and patient-supporting materials to support improvements in the delivery of systemic therapy in the UK.
The ACP provided specialist advice to the Health and Social Care Committee’s Expert Panel on Cancer Services. The panel was established to conduct an independent evaluation of the Government’s progress against its policy commitments in the area of cancer services in England. The ACP is also a member of the Inequalities in Health Alliance, a muti-professional collaborative group launched by the RCP in 2020, to campaign for a cross-government strategy to address and reduce health inequalities.
Financial review
Financially, the ACP's main source of income is from members subscriptions, with additional sponsorship and educational grants from the pharmaceutical industry to support educational activities. SAS is contracted to manage the ACP’s educational meetings, in additional to maintaining the membership database and responsibility for the collection of subscription income. It is hoped that this will maximise subscription income going forward. The current account runs in credit. Travel costs incurred by Executive members and secretarial costs are the main expenditures, although travel continued to be severely restricted in 2021, with a move to meetings being held virtually. Further substantial expenditure was on educational events and publishing activities supported by receipt of restricted and unrestricted Educational Grants and sponsorships.
- 2 -
THE ASSOCIATION OF CANCER PHYSICIANS
TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
Reserves Policy
The association ensures there is sufficient money to meet its annual commitments. A separate fund entitled the McElwain Fund also exists for the presentation of prizes and scholarships in respect of studies to advance the objectives of the association.
At the year end unrestricted reserves were £66,277 (2020: £66,478) and restricted reserves were £65,231 (2020: £52,037).
The trustees have assessed the major risks to which the constitution is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.
Structure, governance and management
The Association of Cancer Physicians was set up in 1985 and then formally adopted the constitution on 29 March 1993 and was registered by the charity commission on 28 January 1994 (charity number 1032256).
The trustees who served during the year were: Dr C Gallagher (Resigned 1 March 2021) Dr A Jones Professor R Begent (Appointed 24 February 2021)
New trustees are appointed by the Executive Committee and 2-3 nominations were made this year who are being approached about serving in this capacity. Particular emphasis is placed upon the appointment of trustees with knowledge and experience relevant to the charity's charitable activities as well as other trustees with the specialty to offer complementary skills eg accounting and marketing.
Public Benefit Statement
Guidance from the Charity Commission has been used to review and develop The Association of Cancer Physicians aims and objectives so that activities are clearly focused to derive good public benefit.
The trustees report was approved by the Board of Trustees.
.............................. Dr A Jones
Date: .............................................
- 3 -
THE ASSOCIATION OF CANCER PHYSICIANS
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF THE ASSOCIATION OF CANCER PHYSICIANS
I report to the trustees on my examination of the financial statements of The Association of Cancer Physicians (the constitution) for the year ended 31 December 2021.
Responsibilities and basis of report
As the trustees of the constitution you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act).
I report in respect of my examination of the constitution’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
-
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1 accounting records were not kept in respect of the constitution as required by section 130 of the 2011 Act; or
-
2 the financial statements do not accord with those records; or
-
3 the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Rouse Partners LLP
55 Station Road Beaconsfield Buckinghamshire HP9 1QL
Dated: .........................
- 4 -
THE ASSOCIATION OF CANCER PHYSICIANS
STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2021
| Unrestricted Restricted funds funds 2021 2021 Notes £ £ Income and endowments from: Donations and legacies 2 68,420 71,492 Investments 3 - 1 Other income 4 - - Total income 68,420 71,493 Expenditure on: Charitable activities 5 68,621 58,299 Gross transfers between funds - - Net (expenditure)/income for the year/ Net movement in funds (201) 13,194 Fund balances at 1 January 2021 66,478 52,037 Fund balances at 31 December 2021 66,277 65,231 |
Total Unrestricted Restricted funds funds 2021 2020 2020 £ £ £ 139,912 34,880 55,717 1 - 10 - 5,001 419 139,913 39,881 56,146 126,920 27,726 27,411 - 18,448 (18,448) 12,993 30,603 10,287 118,515 35,875 41,750 131,508 66,478 52,037 |
Total 2020 £ 90,597 10 5,420 |
|---|---|---|
| 96,027 | ||
| 55,137 | ||
| - 40,890 77,625 |
||
| 118,515 |
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
- 5 -
THE ASSOCIATION OF CANCER PHYSICIANS
BALANCE SHEET
AS AT 31 DECEMBER 2021
| Notes Current assets Debtors 9 Cash at bank and in hand Creditors: amounts falling due within one year 10 Net current assets Income funds Restricted funds 11 Unrestricted funds |
2021 £ 28,543 106,118 134,661 (3,153) |
£ 131,508 65,231 66,277 131,508 |
2020 £ 47,947 81,842 129,789 (11,274) |
£ 118,515 |
|---|---|---|---|---|
| 52,037 66,478 |
||||
| 118,515 |
The financial statements were approved by the Trustees on .........................
.............................. Dr A Jones Trustee
- 6 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021
1 Accounting policies
Company information
The Association of Cancer Physicians is an unincorporated association, constituted under a Governing Document dated 29 March 1993 and is a registered charity in the United Kingdom reference 1032256. The address of the registered office is given on the legal and administrative information page of these financial statements.
1.1 Accounting convention
These accounts have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”), “Accounting and Reporting by Charities” the Statement of Recommended Practice for charities applying FRS 102, the Charities Act 2011 and UK Generally Accepted Accounting Practice as it applies from 1 January 2015. The constitution has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows. The constitution is a Public Benefit Entity as defined by FRS 102.
The financial statements are prepared in sterling, which is the functional currency of the constitution. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2 Going concern
At the time of approving the financial statements, the trustees have a reasonable expectation that the constitution has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3 Charitable funds
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
1.4 Incoming resources
Income is recognised when the constitution is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
All incoming resources are included in the Statement of Financial Activities (SOFA) when receivable.
Grants receivable are recognised when all performance conditions are satisfied and they have been received.
- 7 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
1 Accounting policies
(Continued)
1.5 Resources expended
All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Expenditure is recognised where there is a legal or constructive obligation to make payments to third parties, it is probable that the settlement will be required and the amount of the obligation can be measured reliably. It is categorised under the following headings:
Expenditure on charitable activities includes support and governance costs which are incurred in running the charity.
Support costs are those that assist the work of the charity and include office costs, governance costs and administrative costs. They are incurred directly in support of expenditure on the objects of the charity and allocated to expenditure on charitable activities on a basis consistent with use of the resources.
All expenditure is accounted for on an accruals basis and includes irrecoverable VAT. Direct costs are allocated to the particular activity.
1.6 Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7 Financial instruments
The constitution has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the constitution's balance sheet when the constitution becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price.
Basic financial liabilities
Basic financial liabilities, including creditors and bank loans are recognised at transaction.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.
Derecognition of financial liabilities
Financial liabilities are derecognised when the constitution’s contractual obligations expire or are discharged or cancelled.
- 8 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
2 Donations and legacies
| Unrestricted Restricted funds funds £ £ Grants 22,000 71,492 Membership fees & sponsorships 46,420 - 68,420 71,492 For the year ended 31 December 2020 34,880 55,717 |
Total 2021 £ 93,492 46,420 139,912 |
Total 2020 £ 55,717 34,880 |
|---|---|---|
| 90,597 | ||
| 90,597 |
3 Investments
| Interest receivable 4 Other income Royalties 5 Charitable activities Prizes Meeting and Travel Expenses Publishing Services Share of governance costs |
Restricted Restricted funds funds 2021 2020 £ £ 1 10 Total Unrestricted Restricted Total funds funds 2021 2020 2020 2020 £ £ £ £ - 5,001 419 5,420 2021 2020 £ £ 3,300 3,025 95,941 19,253 9,000 17,000 108,241 39,278 18,679 15,859 126,920 55,137 |
Restricted Restricted funds funds 2021 2020 £ £ 1 10 Total Unrestricted Restricted Total funds funds 2021 2020 2020 2020 £ £ £ £ - 5,001 419 5,420 2021 2020 £ £ 3,300 3,025 95,941 19,253 9,000 17,000 108,241 39,278 18,679 15,859 126,920 55,137 |
|---|---|---|
| Total 2020 £ 5,420 |
||
| 2020 £ 3,025 19,253 17,000 |
||
| 39,278 15,859 |
||
| 55,137 |
- 9 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
6 Support costs
| Support costs Governance costs £ £ Secretarial Services - 15,459 Independent examination - 3,150 Bank charges - 70 - 18,679 Analysed between Charitable activities - 18,679 |
2021 £ 15,459 3,150 70 18,679 18,679 |
2020 Basis of allocation £ 11,633 Governance 4,164 Governance 62 Governance 15,859 15,859 |
|---|---|---|
7 Trustees
None of the trustees (or any persons connected with them) received any remuneration during the year.
8 Employees
The average monthly number of employees during the year was:
| The average monthly number of employees during the year was: | |||
|---|---|---|---|
| 2021 | 2020 | ||
| Number | Number | ||
| Total | - | - | |
| There were no employees whose annual remuneration was more than £60,000. | |||
| 9 | Debtors | ||
| 2021 | 2020 | ||
| Amounts falling due within one year: | £ | £ | |
| Trade debtors | 12,500 | - | |
| Other debtors | 16,043 | 47,947 | |
| 28,543 | 47,947 | ||
| 10 | Creditors: amounts falling due within one year | ||
| 2021 | 2020 | ||
| £ | £ | ||
| Accruals and deferred income | 3,153 | 11,274 |
- 10 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
11 Restricted funds
The restricted fund in relation to the McElwain fund is a separate fund that exists for the award of prizes and scholarships in respect of educational and research studies to advance the objects of the association.
The New Consultants Weekend fund was set up to specifically support senior trainees and consultants in the first 5 years of their appointments. An annual event is held to allow discussions both amongst themselves and with invited more senior mentors about topics facing them at this point in their career.
The Bagshawe Lecture Fund was established following a donation by the trustees of the Post Natal Chorionepithelioma Trust (PNCT) when the charity was dissolved in 2018. The funds support an annual named “Bagshawe” lecture. In 2020 the lecture was given by Professor Afshin Gangi (Professor of Radiology in Strasbourg, France) during the ACP Interventional Oncology Workshop in Bristol in October.
The Interventional Oncology Fund was set up to support a joint interdisciplinary meeting held in October 2021 between the ACP and the British Society of Interventional Oncology (BSIR), to highlight some of the new advances in the rapidly expanding field of interventional oncology. The meeting is being followed up with a book, to be published by EBN Health, due for publication in late 2022.
The ACP Problem Solving in Oncology Webinar fund was set up to support a series of monthly teaching webinars which were launched in October 2020. Sponsored by pharmaceutical companies and hosted on Zoom, the live webinars were initially started to provide additional teaching to compensate for the reduction in local, regional and national educational opportunities during the COVID-19 pandemic. Due to their popularity, the live webinars continue on a monthly basis and are recorded, with the recordings available free of charge to ACP members.
| recordings available free of charge to ACP members. | ||||||||
|---|---|---|---|---|---|---|---|---|
| Movement in funds | Movement | in funds | ||||||
| Balance at | Incoming | Resources | Transfer from | Balance at | Incoming | Resources |
Balance at | |
| 1 January | resources | expended | unrestricted | 1 January | resources | expended 31 December |
||
| 2020 | funds | 2021 | 2021 | |||||
| £ | £ | £ | £ | £ | £ | £ | £ | |
| McElwain | 11,305 | 10 | (3,025) | - | 8,290 | 1 | (3,300) | 4,991 |
| New Consultants Weekend | 38,644 | 7,833 | (2,114) | (30,000) | 14,363 | 14,417 | (16,865) | 11,915 |
| Immunotherapy Workshop | 14,219 | 2,500 | (3,157) | (13,562) | - | - | - | - |
| Problem Solving in Patient Centred and Integrated Cancer | ||||||||
| Care Publication | (22,418) | - | - | 22,418 | - | - | - | - |
| Bagshawe Lecture | - | 29,384 | - | - | 29,384 | - | - | 29,384 |
| Cancer and Fertility Publication | - | 16,419 | (19,115) | 2,696 | - | - | - | - |
| BSIR Interventional Oncology Study Day and Publication | - | - | - | - | - | 49,950 | (32,758) | 17,192 |
| Oncology Webinar Series | - | - | - | - | - | 7,125 | (5,376) | 1,749 |
| 41,750 | 56,146 | (27,411) | (18,448) | 52,037 | 71,493 | (58,299) | 65,231 |
- 11 -
THE ASSOCIATION OF CANCER PHYSICIANS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021
| 12 Analysis of net assets between funds Unrestricted Restricted 2021 2021 £ £ Fund balances at 31 December 2021 are represented by: Current assets/(liabilities) 66,277 65,231 66,277 65,231 |
Total Unrestricted Restricted 2021 2020 2020 £ £ £ 131,508 66,478 52,037 131,508 66,478 52,037 |
Total 2020 £ 118,515 |
|---|---|---|
| 118,515 |
13 Related party transactions
There were no disclosable related party transactions during the year.
- 12 -